Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 | EPC - European Pharmaceutical Contractor | journal | 0.100 Q4 | 3 | 60 | 181 | 230 | 2 | 169 | 0.01 | 3.83 |  |
| 163 | GMP Review | trade journal | 0.100 Q4 | 2 | 6 | 56 | 20 | 2 | 55 | 0.05 | 3.33 | |
| 162 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 91 | 376 | 146 | 2 | 335 | 0.00 | 1.60 | |
| 161 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 62 | 194 | 116 | 0 | 191 | 0.00 | 1.87 | |
| 160 | Pharmacy News | journal | 0.100 Q4 | 1 | 0 | 123 | 0 | 0 | 50 | 0.00 | 0.00 | |
| 159 | Sp2 | trade journal | 0.100 Q4 | 2 | 37 | 123 | 16 | 0 | 103 | 0.00 | 0.43 | |
| 158 | Journal of Applied Therapeutic Research | journal | 0.101 Q4 | 8 | 0 | 17 | 0 | 0 | 17 | 0.00 | 0.00 | |
| 157 | PharmacoVigilance Review | journal | 0.101 Q4 | 2 | 5 | 52 | 19 | 0 | 34 | 0.00 | 3.80 | |
| 156 | Innovations in Pharmaceutical Technology | trade journal | 0.102 Q4 | 9 | 55 | 76 | 162 | 3 | 70 | 0.04 | 2.95 | |
| 155 | Quality Assurance Journal | journal | 0.103 Q4 | 11 | 0 | 13 | 0 | 2 | 11 | 0.00 | 0.00 | |
| 154 | Pharmaceutical Journal | journal | 0.105 Q4 | 28 | 334 | 1450 | 216 | 32 | 661 | 0.01 | 0.65 | |
| 153 | Industrial Pharmacy | trade journal | 0.106 Q4 | 5 | 16 | 59 | 110 | 6 | 59 | 0.05 | 6.88 | |
| 152 | International Journal of Green Nanotechnology | journal | 0.106 Q4 | 5 | 1 | 10 | 33 | 1 | 9 | 0.10 | 33.00 | |
| 151 | EBR - European Biopharmaceutical Review | journal | 0.111 Q4 | 6 | 45 | 183 | 260 | 6 | 177 | 0.03 | 5.78 | |
| 150 | European Pharmaceutical Review | trade journal | 0.112 Q4 | 9 | 54 | 143 | 883 | 16 | 143 | 0.07 | 16.35 | |
| 149 | ONdrugDelivery | trade journal | 0.121 Q4 | 7 | 54 | 139 | 190 | 9 | 108 | 0.08 | 3.52 | |
| 148 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.143 Q4 | 7 | 13 | 70 | 142 | 16 | 55 | 0.22 | 10.92 | |
| 147 | Drug Discovery World | journal | 0.144 Q4 | 14 | 39 | 124 | 385 | 30 | 111 | 0.17 | 9.87 | |
| 146 | Drugs in Context | journal | 0.161 Q4 | 36 | 7 | 16 | 361 | 15 | 14 | 0.94 | 51.57 | |
| 145 | Issues in Toxicology | book series | 0.164 Q4 | 18 | 54 | 126 | 4628 | 34 | 116 | 0.29 | 85.70 | |
| 144 | Expert Opinion on Orphan Drugs | journal | 0.191 Q3 | 27 | 130 | 100 | 8468 | 52 | 100 | 0.52 | 65.14 | |
| 143 | Regulatory Rapporteur | trade journal | 0.195 Q3 | 7 | 74 | 214 | 449 | 21 | 174 | 0.08 | 6.07 | |
| 142 | Journal of Generic Medicines (discontinued) | journal | 0.213 Q3 | 16 | 28 | 92 | 219 | 27 | 82 | 0.23 | 7.82 | |
| 141 | Chemical Speciation and Bioavailability | journal | 0.231 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 140 | Journal of Pharmaceutical Health Services Research | journal | 0.231 Q2 | 19 | 34 | 106 | 1011 | 68 | 95 | 0.68 | 29.74 | |
| 139 | Pharmaceutical Medicine | journal | 0.246 Q3 | 25 | 21 | 62 | 453 | 53 | 57 | 0.62 | 21.57 | |
| 138 | Toxin Reviews | journal | 0.249 Q4 | 54 | 28 | 30 | 1686 | 31 | 29 | 0.82 | 60.21 | |
| 137 | Pharmacology Research and Perspectives | journal | 0.262 Q2 | 43 | 54 | 16 | 2164 | 14 | 16 | 0.88 | 40.07 | |
| 136 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.266 Q4 | 41 | 55 | 145 | 1779 | 124 | 134 | 0.80 | 32.35 | |
| 135 | ATLA Alternatives to Laboratory Animals | journal | 0.293 Q4 | 65 | 69 | 217 | 1601 | 183 | 155 | 0.79 | 23.20 | |
| 134 | Autonomic and Autacoid Pharmacology | journal | 0.295 Q3 | 24 | 2 | 22 | 56 | 14 | 22 | 0.57 | 28.00 | |
| 133 | Cutaneous and Ocular Toxicology | journal | 0.296 Q4 | 37 | 75 | 205 | 1668 | 236 | 201 | 1.27 | 22.24 | |
| 132 | Journal of Negative Results in BioMedicine | journal | 0.303 Q2 | 25 | 18 | 50 | 507 | 56 | 50 | 1.00 | 28.17 | |
| 131 | BMC Chemical Biology | journal | 0.328 Q3 | 21 | 0 | 7 | 0 | 9 | 7 | 1.80 | 0.00 | |
| 130 | Drug Discovery Today: Therapeutic Strategies | journal | 0.340 Q3 | 31 | 0 | 72 | 0 | 72 | 65 | 0.61 | 0.00 | |
| 129 | International Journal of Computational Biology and Drug Design | journal | 0.359 Q3 | 16 | 24 | 77 | 751 | 56 | 70 | 0.70 | 31.29 | |
| 128 | Pharmaceutical patent analyst | journal | 0.368 Q2 | 20 | 58 | 75 | 388 | 44 | 44 | 0.59 | 6.69 | |
| 127 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.372 Q3 | 54 | 114 | 319 | 3812 | 328 | 314 | 1.13 | 33.44 | |
| 126 | Drug Discovery Today: Disease Models | journal | 0.373 Q3 | 33 | 26 | 91 | 1240 | 64 | 80 | 0.42 | 47.69 | |
| 125 | Personalized Medicine | journal | 0.389 Q3 | 36 | 78 | 272 | 3908 | 310 | 231 | 1.05 | 50.10 | |
| 124 | Food Additives and Contaminants: Part B Surveillance | journal | 0.405 Q3 | 41 | 53 | 145 | 1579 | 149 | 144 | 0.93 | 29.79 | |
| 123 | Journal of Asian Natural Products Research | journal | 0.408 Q2 | 51 | 165 | 516 | 2851 | 577 | 516 | 1.07 | 17.28 | |
| 122 | Journal of Food Biochemistry | journal | 0.408 Q3 | 64 | 68 | 310 | 2721 | 333 | 310 | 0.99 | 40.01 | |
| 121 | SAR and QSAR in Environmental Research | journal | 0.415 Q3 | 54 | 54 | 138 | 2447 | 231 | 135 | 1.68 | 45.31 | |
| 120 | Toxicology and Industrial Health | journal | 0.477 Q3 | 69 | 108 | 327 | 4271 | 531 | 327 | 1.55 | 39.55 | |
| 119 | Journal for ImmunoTherapy of Cancer | journal | 0.486 Q3 | 117 | 42 | 21 | 1801 | 47 | 20 | 2.24 | 42.88 | |
| 118 | Mathematical Medicine and Biology | journal | 0.512 Q3 | 49 | 19 | 56 | 764 | 85 | 54 | 1.38 | 40.21 | |
| 117 | Journal of Chemotherapy | journal | 0.518 Q3 | 56 | 76 | 202 | 1953 | 334 | 170 | 1.79 | 25.70 | |
| 116 | DARU, Journal of Pharmaceutical Sciences | journal | 0.526 Q2 | 58 | 78 | 235 | 2556 | 408 | 212 | 1.78 | 32.77 | |
| 115 | Immunopharmacology and Immunotoxicology | journal | 0.531 Q3 | 61 | 54 | 337 | 2247 | 543 | 329 | 1.56 | 41.61 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data